Skip to content
Showing 21 - 30 of 78 results.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective.
Ramped-up sequencing efforts are helping to identify mutations that might boost transmission or help a virus evade immune responses.
A rapid, at-home COVID-19 test developed in David Ho's lab at Columbia University Vagelos College of Physicians and Surgeons, will receive funding from the New York City Economic Development Corp.
Dr. Ho's team found that the SARS-CoV-2 virus is resistant to several neutralizing monoclonal antibodies and sera from vaccinees.
Dr. David Ho delivered the inaugural Grand Rounds at Columbia University Irving Medical Center.
A new SARS-CoV-2 lineage that shares worrisome similarities is on the rise in New York City, according to a study by scientists at Columbia University Vagelos College of Physicians and Surgeons.
In vitro neutralisation assays show REGEN-COV and AZD7442 are effective against the new SARS-CoV-2 variants
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants.
The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both.
Asian Americans in the arts, law, business, academia, medicine, and philanthropy urged Governor G. Newsom to appoint California Supreme Court Justice Goodwin Liu as the state’s next Attorney General.